Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, 48232-48233 [2017-22436]
Download as PDF
<![CDATA[
48232
Federal Register / Vol. 82, No. 199 / Tuesday, October 17, 2017 / Notices
Acquisition Policy Division, GSA, 202–
969–7207 or email zenaida.delgado@
gsa.gov.
SUPPLEMENTARY INFORMATION:
A. Purpose
[FR Doc. 2017–22450 Filed 10–16–17; 8:45 am]
The Affidavit of Individual Surety SF
28 is used by all executive agencies,
including the Department of Defense, to
obtain information from individuals
wishing to serve as sureties to
Government bonds. To qualify as a
surety on a Government bond, the
individual must show a net worth not
less than the penal amount of the bond
on the SF 28. It is an elective decision
on the part of the maker to use
individual sureties instead of other
available sources of surety or sureties
for Government bonds. We are not
aware if other formats exist for the
collection of this information.
The information on SF 28 is used to
assist the contracting officer in
determining the acceptability of
individuals proposed as sureties.
B. Annual Reporting Burden
Respondents: 500.
Responses per Respondent: 1.
Total Responses: 500.
Hours per Response: 0.3.
Total Burden Hours: 150.
sradovich on DSK3GMQ082PROD with NOTICES
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary for the proper
performance of functions of the FAR,
and whether it will have practical
utility; whether our estimate of the
public burden of this collection of
information is accurate, and based on
valid assumptions and methodology;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways in which we can
minimize the burden of the collection of
information on those who are to
respond, through the use of appropriate
technological collection techniques or
other forms of information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 9000–0001, SF 28,
Affidavit of Individual Surety, in all
correspondence.
VerDate Sep<11>2014
Dated: October 11, 2017.
Lorin S. Curit,
Director, Federal Acquisition Policy Division,
Office of Government-wide Acquisition
Policy, Office of Acquisition Policy, Office
of Government-wide Policy.
17:10 Oct 16, 2017
Jkt 244001
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of Potential
Reviewers To Serve on the Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for possible membership
on the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP) in the National
Institute for Occupational Safety and
Health (NIOSH), World Trade Center
Health Program (WTCHP). The Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel
provides advice and guidance to the
Secretary, Department of Health and
Human Services (HHS); the Director,
Centers for Disease Control and
Prevention (CDC), and the
Administrator, Agency for Toxic
Substances and Disease Registry
(ATSDR) regarding the concept review,
scientific and technical merit of grant
and cooperative agreement assistance
applications, and contract proposals
relating to the causes, prevention, and
control of diseases, disabilities, injuries,
and impairments of public health
significance; exposure to hazardous
substances in the environment; health
promotion and education; and other
related activities that promote health
and well-being. Members and Chairs
shall be selected by the Secretary, HHS,
or other official to whom the authority
has been delegated, on an ‘‘as needed’’
basis in response to specific
applications being reviewed with
expertise to provide advice. Members
will be selected from authorities in the
various fields of prevention and control
of diseases, disabilities, and injuries.
Members of other chartered HHS
advisory committees may serve on the
panel if their expertise is required.
Consideration is given to professional
training and background, points of view
represented, and upcoming applications
to be reviewed by the committee.
SUMMARY:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Nominations for membership on
the WTCHP SEPs must be received no
later than December 15, 2017. Packages
received after this time will not be
considered for the current membership
cycle; but will be kept on file for future
cycles. The membership cycles are
listed under the Advisory Council
Review on the Funding Opportunity
Announcement, which is available at:
https://grants.nih.gov/grants/guide/pafiles/PAR-16-098.html.
ADDRESSES: All nominations should be
mailed to Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop E–74, Atlanta, Georgia 30329,
emailed to wtcscience@cdc.gov, or faxed
to (404) 471–2616.
FOR FURTHER INFORMATION CONTACT: Mia
Wallace, Management Analyst, CDC/
NIOSH/WTCHP, 1600 Clifton Road NE.,
Mailstop E–74, Atlanta, Georgia 30329,
Telephone: (404) 498–2253; Email:
mwallace@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
appointed to serve on a CDC SEP and
can be full-time employees of the U.S.
Government. Current participation on
CDC federal workgroups or prior
experience serving on another federal
advisory committee does not disqualify
a reviewer. However, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Reviewers
appointed to the SEP, CDC are not
considered Special Government
Employees, and will not be required to
file financial disclosure reports.
Nominees interested in serving as a
member on a WTCHP Peer Review
Panel should submit the following
items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, and email address);
• A statement summarizing the
nominee’s Areas of Expertise (include
unique experiences, skills and
knowledge the individual will bring to
the WTCHP), Ethnic/Racial Minority
Status, and Citizenship; and
• A statement confirming that the
nominee is not a registered federal
lobbyist.
DATES:
E:\FR\FM\17OCN1.SGM
17OCN1
48233
Federal Register / Vol. 82, No. 199 / Tuesday, October 17, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Background: The WTCHP is
administered by NIOSH. The James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347
(hereafter referred to as ‘‘the Zadroga
Act’’) was signed by President Obama
on January 2, 2011, and was reauthorized on December 18, 2015. The
Zadroga Act continues monitoring and
treatment activities and requires the
establishment (under Subtitle C) of a
research program on health conditions
resulting from the September 11, 2001,
terrorist attacks. For additional
information on the program please refer
to: https://www.cdc.gov/wtc.
The Zadroga Act lists the following
broad research areas:
• Physical and mental health
conditions that may be related to the
September 11, 2001, terrorist attacks;
• Diagnosing WTC-related health
conditions for which there has been
diagnostic uncertainty; and
• Treating WTC-related health
conditions for which there has been
treatment uncertainty.
Research mentioned in the Zadroga
Act includes epidemiologic and other
research studies on WTC-related health
conditions or emerging conditions
among (1) enrolled WTC responders and
certified-eligible WTC survivors under
treatment; (2) sampled populations
outside the NYC disaster area, in
Manhattan (as far north as 14th Street)
and in Brooklyn; and (3) control
populations, to identify potential for
long-term adverse health effects in less
exposed populations.
Major areas of interest include, but are
not limited to, the following:
Linking 9/11 exposure to health
conditions:
• Cancers, multisystem or
autoimmune, cardiovascular and
neurologic disease (including age at
diagnosis);
• Characterizing patterns of illness
(age, gender, comorbidities, etc.); and
• Characterizing alterations in health
and development for those exposed to
9/11 as children.
Characterizing established WTCrelated diseases and comorbidities:
• Identifying phenotypes, biomarkers,
epigenetics; and
• Care models that address complex
co-morbidities and other modifiable
factors.
• Health services research and valuebased care that addresses disasterrelated injury and illness for chronic
disease.
(Note: Health services research
examines how people get access to
health care, how much care costs, and
what happens to patients as a result of
this care. The main goals of health
services research are to identify the
most effective ways to organize,
manage, finance, and deliver high
quality care; reduce medical errors; and
improve patient safety (Agency for
Healthcare Research and Quality, 2002).
Characterizing the work-ability and
occupational outcomes for those
impacted by 9/11.
Lessons learned in recovery:
• Identifying and operationalizing
key elements of psychological resilience
for disaster responders; and
• Establishing comparison groups for
disaster-related research for key health
indicators for first responders.
(Note: Concepts of psychological
resilience vary across disciplines with
investigations addressing various
outcomes ranging from reported levels
of stress, burnout, compassion fatigue,
and general indicators of well-being.
Also proposed are interpersonal,
intrapersonal and environmental factors
that suggest a more stable and enduring
personality trait impacting selfregulation.)
Relevant diseases or conditions
include, but are not limited to, the
following:
• Respiratory diseases
• Cancer (including detection/diagnosis
of pre-malignant changes)
• Cardiovascular Disease
• Psychological resilience and wellbeing
• Persistent psychiatric conditions such
as posttraumatic stress, anxiety and
depressive disorders
• Cognitive changes
• Aging—the impacts of aging on those
impacted by 9/11 illness and injury
• Neurological Diseases
• Aerodigestive health
• Multisystem or auto-immune diseases
• Gastro-esophageal disorders
• Gastrointestinal health
• Chronic musculoskeletal conditions
resulting from acute traumatic injury
and overuse disorders
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–22436 Filed 10–16–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Form ACF–196R, ‘‘TANF
Quarterly Financial Report’’
OMB No.: 0970–0446
Description: This information
collection is authorized under Section
411(a)(3) of the Social Security Act. This
request is for continued approval of
Form ACF–196R for quarterly financial
reporting under the Temporary
Assistance for Needy Families (TANF)
program. States participating in the
TANF program are required by statute to
report financial data on a quarterly
basis. The forms meet the legal standard
and provide essential data on the use of
federal TANF funds. Failure to collect
the data would seriously compromise
ACF’s ability to monitor program
expenditures, estimate funding needs,
and to prepare budget submissions and
annual reports required by Congress.
Financial reporting under the TANF
program is governed by 45 CFR part
265.
This form was first developed in 2014
to replace Form ACF–196. No changes
are being proposed with this request for
OMB review. No comments were
received in response to the publication
of the initial Federal Register Notice on
May 30, 2017, 82 FR 24714.
Respondents: State agencies
administering the TANF program (50
States plus the District of Columbia)
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total
burden hours
ACF–196R .......................................................................................................
51
4
14
2,856
VerDate Sep<11>2014
17:10 Oct 16, 2017
Jkt 244001
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 82, Number 199 (Tuesday, October 17, 2017)]
[Notices]
[Pages 48232-48233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22436]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Potential Reviewers To Serve on the
Disease, Disability, and Injury Prevention and Control Special Emphasis
Panel
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for possible membership on the Disease, Disability,
and Injury Prevention and Control Special Emphasis Panel (SEP) in the
National Institute for Occupational Safety and Health (NIOSH), World
Trade Center Health Program (WTCHP). The Disease, Disability, and
Injury Prevention and Control Special Emphasis Panel provides advice
and guidance to the Secretary, Department of Health and Human Services
(HHS); the Director, Centers for Disease Control and Prevention (CDC),
and the Administrator, Agency for Toxic Substances and Disease Registry
(ATSDR) regarding the concept review, scientific and technical merit of
grant and cooperative agreement assistance applications, and contract
proposals relating to the causes, prevention, and control of diseases,
disabilities, injuries, and impairments of public health significance;
exposure to hazardous substances in the environment; health promotion
and education; and other related activities that promote health and
well-being. Members and Chairs shall be selected by the Secretary, HHS,
or other official to whom the authority has been delegated, on an ``as
needed'' basis in response to specific applications being reviewed with
expertise to provide advice. Members will be selected from authorities
in the various fields of prevention and control of diseases,
disabilities, and injuries. Members of other chartered HHS advisory
committees may serve on the panel if their expertise is required.
Consideration is given to professional training and background, points
of view represented, and upcoming applications to be reviewed by the
committee.
DATES: Nominations for membership on the WTCHP SEPs must be received no
later than December 15, 2017. Packages received after this time will
not be considered for the current membership cycle; but will be kept on
file for future cycles. The membership cycles are listed under the
Advisory Council Review on the Funding Opportunity Announcement, which
is available at: https://grants.nih.gov/grants/guide/pa-files/PAR-16-098.html.
ADDRESSES: All nominations should be mailed to Centers for Disease
Control and Prevention, 1600 Clifton Road NE., Mailstop E-74, Atlanta,
Georgia 30329, emailed to wtcscience@cdc.gov, or faxed to (404) 471-
2616.
FOR FURTHER INFORMATION CONTACT: Mia Wallace, Management Analyst, CDC/
NIOSH/WTCHP, 1600 Clifton Road NE., Mailstop E-74, Atlanta, Georgia
30329, Telephone: (404) 498-2253; Email: mwallace@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens appointed to serve on a CDC SEP and can
be full-time employees of the U.S. Government. Current participation on
CDC federal workgroups or prior experience serving on another federal
advisory committee does not disqualify a reviewer. However, HHS policy
is to avoid excessive individual service on advisory committees and
multiple committee memberships. Reviewers appointed to the SEP, CDC are
not considered Special Government Employees, and will not be required
to file financial disclosure reports.
Nominees interested in serving as a member on a WTCHP Peer Review
Panel should submit the following items:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number, and
email address);
A statement summarizing the nominee's Areas of Expertise
(include unique experiences, skills and knowledge the individual will
bring to the WTCHP), Ethnic/Racial Minority Status, and Citizenship;
and
A statement confirming that the nominee is not a
registered federal lobbyist.
[[Page 48233]]
Background: The WTCHP is administered by NIOSH. The James Zadroga
9/11 Health and Compensation Act of 2010, Public Law 111-347 (hereafter
referred to as ``the Zadroga Act'') was signed by President Obama on
January 2, 2011, and was re-authorized on December 18, 2015. The
Zadroga Act continues monitoring and treatment activities and requires
the establishment (under Subtitle C) of a research program on health
conditions resulting from the September 11, 2001, terrorist attacks.
For additional information on the program please refer to: https://www.cdc.gov/wtc.
The Zadroga Act lists the following broad research areas:
Physical and mental health conditions that may be related
to the September 11, 2001, terrorist attacks;
Diagnosing WTC-related health conditions for which there
has been diagnostic uncertainty; and
Treating WTC-related health conditions for which there has
been treatment uncertainty.
Research mentioned in the Zadroga Act includes epidemiologic and
other research studies on WTC-related health conditions or emerging
conditions among (1) enrolled WTC responders and certified-eligible WTC
survivors under treatment; (2) sampled populations outside the NYC
disaster area, in Manhattan (as far north as 14th Street) and in
Brooklyn; and (3) control populations, to identify potential for long-
term adverse health effects in less exposed populations.
Major areas of interest include, but are not limited to, the
following:
Linking 9/11 exposure to health conditions:
Cancers, multisystem or autoimmune, cardiovascular and
neurologic disease (including age at diagnosis);
Characterizing patterns of illness (age, gender,
comorbidities, etc.); and
Characterizing alterations in health and development for
those exposed to 9/11 as children.
Characterizing established WTC-related diseases and comorbidities:
Identifying phenotypes, biomarkers, epigenetics; and
Care models that address complex co-morbidities and other
modifiable factors.
Health services research and value-based care that
addresses disaster-related injury and illness for chronic disease.
(Note: Health services research examines how people get access to
health care, how much care costs, and what happens to patients as a
result of this care. The main goals of health services research are to
identify the most effective ways to organize, manage, finance, and
deliver high quality care; reduce medical errors; and improve patient
safety (Agency for Healthcare Research and Quality, 2002).
Characterizing the work-ability and occupational outcomes for those
impacted by 9/11.
Lessons learned in recovery:
Identifying and operationalizing key elements of
psychological resilience for disaster responders; and
Establishing comparison groups for disaster-related
research for key health indicators for first responders.
(Note: Concepts of psychological resilience vary across disciplines
with investigations addressing various outcomes ranging from reported
levels of stress, burnout, compassion fatigue, and general indicators
of well-being. Also proposed are interpersonal, intrapersonal and
environmental factors that suggest a more stable and enduring
personality trait impacting self-regulation.)
Relevant diseases or conditions include, but are not limited to,
the following:
Respiratory diseases
Cancer (including detection/diagnosis of pre-malignant
changes)
Cardiovascular Disease
Psychological resilience and well-being
Persistent psychiatric conditions such as posttraumatic
stress, anxiety and depressive disorders
Cognitive changes
Aging--the impacts of aging on those impacted by 9/11 illness
and injury
Neurological Diseases
Aerodigestive health
Multisystem or auto-immune diseases
Gastro-esophageal disorders
Gastrointestinal health
Chronic musculoskeletal conditions resulting from acute
traumatic injury and overuse disorders
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-22436 Filed 10-16-17; 8:45 am]
BILLING CODE 4163-18-P
